Skip to main content
. 2014 Mar 5;37(5):823–829. doi: 10.1007/s10545-014-9686-7

Fig. 1.

Fig. 1

Percent change in urinary glycosaminoglycan (uGAG) levels from baseline at last available test result for severe MPS II patients on long-term enzyme replacement therapy (ERT). *First available uGAG test result for patient 6 was after 7 months of ERT and for patient 14 was after 6 months of ERT. No baseline data are available. Here we report percent change between first available and last available uGAG test results